<DOC>
	<DOC>NCT01257958</DOC>
	<brief_summary>Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.</brief_summary>
	<brief_title>Vitamin D Pilot Study in Patients With Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis, Relapsing-Remitting</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>relapsing remitting MS MRI contraindicated</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Vitamin D, 19 nor Vitamin D, Multiple Sclerosis</keyword>
</DOC>